Press releases
- Geron Corporation Announces Chief Commercial Officer to Depart at End of August 2024
- Geron to Announce Second Quarter 2024 Financial Results on August 8, 2024
- Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Geron Announces FDA Approval of RYTELO™ (imetelstat), a First-in-Class Telomerase Inhibitor, for the Treatment of Adult Patients with Lower-Risk MDS with Transfusion-Dependent Anemia
- Geron Corporation Reports First Quarter 2024 Financial Results and Business Highlights
- Geron to Announce First Quarter 2024 Financial Results on May 2, 2024
More ▼
Key statistics
As of last trade Geron Corp (GON:FRA) traded at 3.74, -28.08% below its 52-week high of 5.20, set on Jun 07, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.74 |
---|---|
High | 3.74 |
Low | 3.74 |
Bid | 3.74 |
Offer | 3.99 |
Previous close | 4.23 |
Average volume | 5.07k |
---|---|
Shares outstanding | 593.13m |
Free float | 592.61m |
P/E (TTM) | -- |
Market cap | 2.78bn USD |
EPS (TTM) | -0.3464 USD |
Data delayed at least 15 minutes, as of Jul 24 2024 07:06 BST.
More ▼